NDT Advance Access originally published online on December 2, 2005
Nephrology Dialysis Transplantation 2006 21(4):1087-1088; doi:10.1093/ndt/gfi295
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Case Report
Mizoribine induces remission of relapsed ANCA-associated renal vasculitis
1 Department of Internal Medicine, Nagasaki Municipal Medical Center and 2 Second Department of Internal Medicine and 3 Division of Renal Care Unit, Nagasaki University School of Medicine, Nagasaki, Japan
Correspondence and offprint requests to: Yoshiaki Nishioka, MD, Department of Internal Medicine, Nagasaki Municipal Medical Center, 20-5 Fuchi-machi, Nagasaki 852-8012, Japan. Email: yyynnn@mxc.cncm.ne.jp
Keywords: antineutrophil cytoplasmic autoantibody-associated renal vasculitis; mizoribine; relapse; renal dysfunction
| The first 10% of the full text of this article appears below. |
A 70-year-old woman who was diagnosed with antineutrophil cytoplasm antibody (ANCA)-associated renal vasculitis was admitted to our hospital, because of walking difficulties with muscle weakness of both lower extremities and fever with neutropenia. She was treated with 20 mg/day prednisolone and 50 mg/day cyclophosphamide (CYC). Her serum